John Smeraglia

1.5k total citations
28 papers, 885 citations indexed

About

John Smeraglia is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John Smeraglia has authored 28 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in John Smeraglia's work include Biosimilars and Bioanalytical Methods (15 papers), Protein purification and stability (4 papers) and Cell Image Analysis Techniques (4 papers). John Smeraglia is often cited by papers focused on Biosimilars and Bioanalytical Methods (15 papers), Protein purification and stability (4 papers) and Cell Image Analysis Techniques (4 papers). John Smeraglia collaborates with scholars based in Belgium, United Kingdom and United States. John Smeraglia's co-authors include Carlo L. Bello, Charles M. Baum, Philip Timmerman, Samuel E. DePrimo, Laurie Sherman, Brian I. Rini, Robert J. Motzer, Dominic G. Spinella, M. Dror Michaelson and Steve White and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

John Smeraglia

28 papers receiving 857 citations

Peers

Countries citing papers authored by John Smeraglia

Since Specialization

Citations

This map shows the geographic impact of John Smeraglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Smeraglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Smeraglia more than expected).

Fields of papers citing papers by John Smeraglia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Smeraglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Smeraglia. The network helps show where John Smeraglia may publish in the future.

Co-authorship network of co-authors of John Smeraglia

This figure shows the co-authorship network connecting the top 25 collaborators of John Smeraglia. A scholar is included among the top collaborators of John Smeraglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Smeraglia. John Smeraglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS 2022 ·Journal of Chromatography B ·Christine Wegler, Aljona Saleh, Annika Lindqvist, Hedvig Nordeng, John Smeraglia, Paweł Baranczewski	11
2	Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load 2021 ·Journal of Molecular Diagnostics ·Pieter Mestdagh, Michel Gillard, (unknown), Jean‐Paul Pirnay, Jeroen Poels, Jan Hellemans, Veronik Hutse, Céline Vermeiren, Maxime Boutier, Veerle De Wever, Patrick Soentjens, Sarah Djebara, Hugues Malonne, Emmanuel André, Marc Arbyn, John Smeraglia, Jo Vandesompele	6
3	Improving The Sensitivity and Specificity of A Bioanalytical Assay for The Measurement of Certolizumab Pegol 2017 ·Bioanalysis ·John Smeraglia, John‐Paul Silva, (unknown)	4
4	Best Practices for Metabolite Quantification in Drug Development: Updated Recommendation from The European Bioanalysis Forum 2016 ·Bioanalysis ·Philip Timmerman, Stefan Blech, Stephen White, (unknown), Claude Delatour, (unknown), Geert Mannens, John Smeraglia, Stephen J. Williams, Graeme Young	12
5	Tiered Approach Into Practice: Scientific Validation for Chromatography-Based Assays in Early Development – A Recommendation from The European Bioanalysis Forum 2015 ·Bioanalysis ·Philip Timmerman, Stephen White, (unknown), Morten A. Kall, John Smeraglia, Marianne Scheel Fjording, Magnus Knutsson	33
6	Conference Report: AAPS and US FDA Crystal City V Meeting on Quantitative Bioanalytical Method Validation and Implementation: Feedback from The EBF 2014 ·Bioanalysis ·John Smeraglia, (unknown), (unknown), Arjen Companjen, Stephen White, Michaela Golob, (unknown), Peter van Amsterdam, Philip Timmerman	5
7	Feedback from The European Bioanalysis Forum Workshop: Taking Tiered Approach to The Next Level 2014 ·Bioanalysis ·Philip Timmerman, Steve White, Magnus Knutsson, Morten A. Kall, Marianne Scheel Fjording, John Smeraglia, (unknown)	8
8	Assay Formats: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team 2013 ·The AAPS Journal ·Sherri Dudal, Daniel Baltrukonis, (unknown), (unknown), Alison Joyce, (unknown), John Smeraglia, Yoshitaka Taniguchi, Jihong Yang	30
9	Conference Report: The 3Rd Ebf Focus Meeting: ‘Hatching’ – Emerging Technologies Approaching The Regulated Bioanalysis Laboratory 2012 ·Bioanalysis ·(unknown), Neil Henderson, Benno Ingelse, (unknown), John Smeraglia, Philip Timmerman, (unknown), Arjen Companjen, Peter van Amsterdam	3
10	EBF Recommendation on the Validation of Bioanalytical Methods for Dried Blood Spots 2011 ·Bioanalysis ·Philip Timmerman, Steve White, (unknown), Silke Lüdtke, (unknown), John Smeraglia	143
11	Conference Report: from Challenges to Solutions 2011 ·Bioanalysis ·Richard Abbott, Ben Gordon, Peter van Amsterdam, Berthold Lausecker, (unknown), John Smeraglia, (unknown), (unknown), Michaela Golob, Magnus Knutsson, Christian Herling, (unknown), Philip Timmerman	5
12	Conference Report: Discussion on Harmonization and Globalization of Bioanalytical Guidances at The 19th International Reid Bioanalytical Forum 2011 ·Bioanalysis ·Fabio Garofolo, John Smeraglia, (unknown), Mark Seymour, Howard Hill	2
13	Pharmacokinetics of sunitinib malate in subjects with hepatic impairment 2010 ·Cancer Chemotherapy and Pharmacology ·Carlo L. Bello, May Garrett, Laurie Sherman, John Smeraglia, Bob Ryan, Melvin Toh	31
14	A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects 2007 ·Cancer Research ·Carlo L. Bello, Hai‐Zhi Bu, Shem Patyna, Ping Kang, Geoffrey W. Peng, William F. Pool, John Smeraglia, Laurie Sherman, May Garrett, Karen J. Klamerus	6
15	Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins 2007 ·Journal of Translational Medicine ·Samuel E. DePrimo, Carlo L. Bello, John Smeraglia, Charles M. Baum, Dominic G. Spinella, Brian I. Rini, M. Dror Michaelson, Robert J. Motzer	255
16	731 POSTER Open-label, single-dose, phase I study evaluating the mass balance and pharmacokinetics (PKs) of sunitinib (SU) in healthy male subjects 2007 ·European Journal of Cancer Supplements ·Laurie Sherman, Geoffrey W. Peng, Shem Patyna, W F Pool, John Smeraglia, Carlo L. Bello, (unknown), Karen J. Klamerus	4
17	Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects 2006 ·Anti-Cancer Drugs ·Carlo L. Bello, Laurie Sherman, Jihao Zhou, Lev Verkh, John Smeraglia, (unknown), Karen J. Klamerus	114
18	Effect of treatment with sunitinib malate, a multitargeted tyrosine kinase inhibitor, on circulating plasma levels of VEGF, soluble VEGF receptors 2 and 3, and soluble KIT in patients with metastatic breast cancer 2006 ·Journal of Clinical Oncology ·(unknown), (unknown), Xin Huang, John Smeraglia, Laurie Sherman, Mary Collier, Charles M. Baum, Anthony Elias, Harold J. Burstein, Kathy D. Miller	24
19	Analysis of circulating biomarkers of sunitinib malate in patients with unresectable neuroendocrine tumors (NET): VEGF, IL-8, and soluble VEGF receptors 2 and 3 2006 ·Journal of Clinical Oncology ·Carlo L. Bello, Samuel E. DePrimo, (unknown), John Smeraglia, Laurie Sherman, L. Tye, Charles M. Baum, Neal J. Meropol, Heinz‐Josef Lenz, Matthew H. Kulke	38
20	Matrix effects and selectivity issues in LC-MS-MS 2002 ·Chromatographia ·John Smeraglia, (unknown), David G. Watson	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact